Jennifer Alexandra was 37 years old when she was diagnosed with tongue cancer and needed to have her tongue removed after doctors discovered a blueberry-sized tumor in her mouth.
“Space-based research has a long history of contributing to advancements on Earth,” said Dr. Lisa Carnell.
The International Space Station (ISS) has been a beacon of scientific and medical research ever since the station’s first module was launched in 1999, as astronauts continue to push the boundaries regarding microgravity research that has contributed to advancing science and medical knowledge back on Earth. To continue this, NASA and the ISS National Laboratory recently announced a partnership through the ISS National Lab Research Announcement (NLRA) 2024-09: Igniting Innovation: Science in Space to Cure Disease on Earth that will provide up to $4 million with the goal of helping to advance disease diagnosis and treatment back on Earth.
Through collaboration between government agencies, industry, and academia, the NLRA hopes to accomplish several objectives pertaining to developing medical technologies on Earth, including disease mechanism models, population and disease diversity, drug discovery & development, drug delivery, and drug resistance. This announcement comes after the ISS National Laboratory announced in July 2024 that five projects were selected for the Cancer Research in Space for Life on Earth with the goal of providing $7 million in grants to advance cancer research in microgravity onboard the ISS.
Engineers have designed a tiny battery, smaller than a grain of sand, to power microscopic robots for jobs such as drug delivery or locating leaks in gas pipelines.
A tiny battery designed by MIT engineers could enable the deployment of cell-sized, autonomous robots for drug delivery within in the human body, as well as other applications such as locating leaks in gas pipelines.
The new battery, which is 0.1 millimeters long and 0.002 millimeters thick — roughly the thickness of a human hair — can capture oxygen from air and use it to oxidize zinc, creating a current with a potential of up to 1 volt. That is enough to power a small circuit, sensor, or actuator, the researchers showed.
Continue reading “MIT engineers design tiny batteries for powering cell-sized robots” »
New study shows ‘#Dancing #Molecules’ can #Regenerate #Cartilage in 3 days.
In the new study, the treatment activated gene expression needed to regenerate cartilage in just 4h. After 3 days, cells produced protein components for cartilage regeneration…
In November 2021, Northwestern University researchers introduced an injectable new therapy, which harnessed fast-moving “dancing molecules,” to repair tissues and reverse paralysis after severe spinal cord injuries.
Continue reading “New study shows ‘Dancing Molecules’ can Regenerate Cartilage in 3 days” »
The pursuit of a cure for Alzheimer’s disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies.
In July 2022, Science magazine reported that a key 2006 research paper, published in the prestigious journal Nature, which identified a subtype of brain protein called beta-amyloid as the cause of Alzheimer’s, may have been based on fabricated data.
One year earlier, in June 2021, the US Food and Drug Administration had approved aducanumab, an antibody-targeting beta-amyloid, as a treatment for Alzheimer’s, even though the data supporting its use were incomplete and contradictory.
ROCHESTER, Minn. — Mayo Clinic scientists are using artificial intelligence (AI) and machine learning to analyze electroencephalogram (EEG) tests more quickly and precisely, enabling neurologists to find early signs of dementia among data that typically go unexamined.
The century-old EEG, during which a dozen or more electrodes are stuck to the scalp to monitor brain activity, is often used to detect epilepsy. Its results are interpreted by neurologists and other experts trained to spot patterns among the test’s squiggly waves.
The Texas Heart Institute (THI) and BiVACOR®, a clinical-stage medical device company, announced today the successful first-in-human implantation of the BiVACOR Total Artificial Heart (TAH) as part of the U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS) on July 9, 2024.
BiVACOR’s TAH is a titanium-constructed biventricular rotary blood pump with a single moving part that utilizes a magnetically levitated rotor that pumps the blood and replaces both ventricles of a failing heart.
They should not replace your doctor yet.
New research found that ChatGPT was only able to correctly diagnose less than half the medical cases it was asked to look at.
Gut health has been making headlines for years, but its impact on heart health is only now unfolding. A new study from Cleveland Clinic and Tufts University researchers has uncovered a link between gut bacteria and heart health that could revolutionize cardiovascular care for seniors. This groundbreaking research suggests that the key to a healthy heart in our later years might be influenced by the microscopic inhabitants of our digestive system.
The study, published in Circulation: Heart Failure, followed nearly 12,000 initially healthy participants for almost 16 years. Researchers focused on the gut microbe called trimethylamine N-oxide (TMAO), which is produced when gut bacteria digest certain nutrients found in red meat and other animal products. The researchers discovered that elevated levels of TMAO in the blood were strongly associated with a higher risk of developing heart failure, even after accounting for other known risk factors.
Stanley Hazen, MD, PhD, chair of Cardiovascular and Metabolic Sciences in Cleveland Clinic’s Lerner Research Institute and the study’s senior author, emphasized the significance of these findings for predicting heart failure risk in seemingly healthy individuals. “Regular measurement of blood TMAO levels predicted incident risk for heart failure development during long-term follow-up,” he explained. This discovery opens new possibilities for early intervention and prevention strategies, particularly important for the elderly population who are at higher risk for heart-related issues.
Not in leading research but interesting.
According to a new study, a polyphenol-rich natural extract positively impacts lifespan, healthspan, and cellular senescence. These results were observed in both cell culture and a mouse model [1].
Traditional and folk medicines offer many botanical extracts that can be tested by modern science for their medicinal properties and influences on aging. One such plant is the Bolivian prawn sage (Salvia haenkei).
Continue reading “A Botanical Extract Extends Lifespan and Healthspan in Mice” »
